Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 22,000 BIOA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | BioAge Labs, Inc. (BIOA) | Grant/Award | 22,000 | n/a |
| Jun 10, 2026 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 15,200 | n/a |
| May 4, 2026 | Seaport Therapeutics, Inc. (SPTX) | Conversion | 1,927,159 | n/a |
| Jun 18, 2025 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 21,850 | n/a |
| Jun 9, 2025 | BioAge Labs, Inc. (BIOA) | Grant/Award | 22,000 | n/a |
| Apr 30, 2025 | Natera, Inc. (NTRA) | Grant/Award | 142 | n/a |
| Feb 5, 2025 | Natera, Inc. (NTRA) | Grant/Award | 114 | n/a |
| Oct 30, 2024 | Natera, Inc. (NTRA) | Grant/Award | 153 | n/a |
| Sep 27, 2024 | BioAge Labs, Inc. (BIOA) | Conversion | 1,638,236 | n/a |
| Jul 31, 2024 | Natera, Inc. (NTRA) | Grant/Award | 177 | n/a |